248 related articles for article (PubMed ID: 12546269)
1. Risedronate prevents hip fractures, but who should get therapy?
Deal CL
Cleve Clin J Med; 2002 Dec; 69(12):964, 968-70, 973-6. PubMed ID: 12546269
[TBL] [Abstract][Full Text] [Related]
2. [Bisphosphonate treatment prevents hip fractures in 70-79 year old women with osteoporotic vertebral fractures].
Netelenbos JC
Ned Tijdschr Geneeskd; 2001 Jul; 145(28):1336-8. PubMed ID: 11484428
[TBL] [Abstract][Full Text] [Related]
3. Health-economic comparison of three recommended drugs for the treatment of osteoporosis.
Brecht JG; Kruse HP; Möhrke W; Oestreich A; Huppertz E
Int J Clin Pharmacol Res; 2004; 24(1):1-10. PubMed ID: 15575171
[TBL] [Abstract][Full Text] [Related]
4. Effect of risedronate on the risk of hip fracture in elderly women. Hip Intervention Program Study Group.
McClung MR; Geusens P; Miller PD; Zippel H; Bensen WG; Roux C; Adami S; Fogelman I; Diamond T; Eastell R; Meunier PJ; Reginster JY;
N Engl J Med; 2001 Feb; 344(5):333-40. PubMed ID: 11172164
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological interventions for the prevention of vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: does site-specificity exist?
Compston JE
Bone; 2000 Dec; 27(6):765-8. PubMed ID: 11113386
[No Abstract] [Full Text] [Related]
6. Effectiveness of risedronate and alendronate on nonvertebral fractures: an observational study through 2 years of therapy.
Lindsay R; Watts NB; Lange JL; Delmas PD; Silverman SL
Osteoporos Int; 2013 Aug; 24(8):2345-52. PubMed ID: 23612793
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness of bisphosphonates on nonvertebral and hip fractures in the first year of therapy: the risedronate and alendronate (REAL) cohort study.
Silverman SL; Watts NB; Delmas PD; Lange JL; Lindsay R
Osteoporos Int; 2007 Jan; 18(1):25-34. PubMed ID: 17106785
[TBL] [Abstract][Full Text] [Related]
8. Longitudinal change in clinical fracture incidence after initiation of bisphosphonates.
Abelson A; Ringe JD; Gold DT; Lange JL; Thomas T
Osteoporos Int; 2010 Jun; 21(6):1021-9. PubMed ID: 19722103
[TBL] [Abstract][Full Text] [Related]
9. Risedronate therapy for prevention of hip fracture after stroke in elderly women.
Poole KE; Warburton EA; Reeve J
Neurology; 2005 Nov; 65(9):1513-4; author reply 1513-4. PubMed ID: 16275859
[No Abstract] [Full Text] [Related]
10. Do bisphosphonates reduce the risk of osteoporotic fractures? An evaluation of the evidence to date.
Hodsman AB; Hanley DA; Josse R
CMAJ; 2002 May; 166(11):1426-30. PubMed ID: 12054412
[No Abstract] [Full Text] [Related]
11. Risedronate treatment and extended fracture protection in postmenopausal women.
Harris ST
Clin Exp Rheumatol; 2001; 19(6):625-6. PubMed ID: 11791630
[No Abstract] [Full Text] [Related]
12. Risedronate increases bone mineral density and reduces the vertebral fracture incidence in postmenopausal women.
Reginster JY
Clin Exp Rheumatol; 2001; 19(2):121-2. PubMed ID: 11326471
[No Abstract] [Full Text] [Related]
13. Risedronate versus alendronate in older patients with osteoporosis at high risk of fracture: an Italian cost-effectiveness analysis.
Berto P; Maggi S; Noale M; Lopatriello S
Aging Clin Exp Res; 2010 Apr; 22(2):179-88. PubMed ID: 20145427
[TBL] [Abstract][Full Text] [Related]
14. The prevention of hip fracture with risedronate and ergocalciferol plus calcium supplementation in elderly women with Alzheimer disease: a randomized controlled trial.
Sato Y; Kanoko T; Satoh K; Iwamoto J
Arch Intern Med; 2005 Aug 8-22; 165(15):1737-42. PubMed ID: 16087821
[TBL] [Abstract][Full Text] [Related]
15. Pharmacoeconomic analysis of osteoporosis treatment with risedronate.
Brecht JG; Kruse HP; Felsenberg D; Möhrke W; Oestreich A; Huppertz E
Int J Clin Pharmacol Res; 2003; 23(4):93-105. PubMed ID: 15224498
[TBL] [Abstract][Full Text] [Related]
16. Aging bone and osteoporosis: strategies for preventing fractures in the elderly.
Ettinger MP
Arch Intern Med; 2003 Oct; 163(18):2237-46. PubMed ID: 14557222
[TBL] [Abstract][Full Text] [Related]
17. Risedronate sodium therapy for prevention of hip fracture in men 65 years or older after stroke.
Sato Y; Iwamoto J; Kanoko T; Satoh K
Arch Intern Med; 2005 Aug 8-22; 165(15):1743-8. PubMed ID: 16087822
[TBL] [Abstract][Full Text] [Related]
18. Randomized trial of the effects of risedronate on vertebral fractures in women with established postmenopausal osteoporosis. Vertebral Efficacy with Risedronate Therapy (VERT) Study Group.
Reginster J; Minne HW; Sorensen OH; Hooper M; Roux C; Brandi ML; Lund B; Ethgen D; Pack S; Roumagnac I; Eastell R
Osteoporos Int; 2000; 11(1):83-91. PubMed ID: 10663363
[TBL] [Abstract][Full Text] [Related]
19. Reducing hip fracture risk with risedronate in elderly women with established osteoporosis.
Masud T; McClung M; Geusens P
Clin Interv Aging; 2009; 4():445-9. PubMed ID: 19966913
[TBL] [Abstract][Full Text] [Related]
20. Risedronate for the prevention and treatment of postmenopausal osteoporosis.
Cranney A; Waldegger L; Zytaruk N; Shea B; Weaver B; Papaioannou A; Robinson V; Wells G; Tugwell P; Adachi JD; Guyatt G
Cochrane Database Syst Rev; 2003; (4):CD004523. PubMed ID: 14584020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]